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Abstract Lymphocyte-oriented kinase (LOK) is a member of
the STE20/p21-activated kinase (PAK) family and expressed
predominantly in lymphoid organs. Generation of LOK-deficient
mice revealed that the leukocyte-function-associated antigen
(LFA-1)/intercellular adhesion molecules (ICAM)-mediated ag-
gregation of mitogen-stimulated T cells was greatly enhanced in
the absence of LOK. Though levels of total LFA-1 and ICAMs
as well as the active form of LFA-1 on T cell blasts were
comparable in the presence and absence of LOK, clustering of
active LFA-1 detected by binding of soluble ICAM-1 was
accelerated in the absence of LOK. These results suggest that
LOK is potentially involved in the regulation of LFA-1-mediated
lymphocyte adhesion.
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The STE20/p21-activated kinase (PAK) family is a growing
family of serine/threonine kinases which have been implicated
in the regulation of a number of cellular activities such as
mitogen-activated protein (MAP) kinase signaling pathways,
apoptosis, cell cycle and cytoskeletal dynamics [1^4]. This
family can be divided into two major subfamilies based on
their structure [1]. The PAK subfamily members such as yeast
Ste20p and mammalian PAK have a kinase domain at the
C-terminus and a conserved p21 Rac and Cdc42-binding do-
main (regulatory domain) at the N-terminus. On the other
hand, the germinal center kinase (GCK) subfamily members
lack the p21 Rac/Cdc42-binding domain and have a kinase
domain at the N-terminus and a putative regulatory domain
at the C-terminus. The members of the PAK subfamily were
initially considered to lie at the top of the MAP kinase cas-
cade and activate the cascade [1,2]. Recently, however, there
are growing volume of studies focusing on the role of the
PAK subfamily as a upstream regulator of cell morphogenesis
and actin cytoskeleton [1^3]. On the other hand, the role of
the GCK subfamily besides in the regulation of MAP kinase
pathway remains largely unknown [4].
We previously cloned a novel protein kinase gene, lok (lym-
phocyte-oriented kinase) [5,6]. It codes for a 130-kDa serine/
threonine kinase which is expressed predominantly in lym-
phoid organs. LOK carries a kinase domain homologous to
that of the STE20/PAK family members at the N-terminus, a
long coiled-coil structure at the C-terminus and a proline-rich
region in between. Thus, LOK is a new member of the GCK
subfamily. In contrast to many other members of the STE20/
PAK family, LOK activated none of the known MAP kinase
isoforms as far as analyzed in COS7 cells. These results sug-
gested that LOK could be involved in a novel signaling path-
way distinct from the known MAP kinase cascades in lym-
phocytes. To clarify the physiological role of LOK in vivo, we
generated LOK-de¢cient mice by gene targeting. Our results
suggest that LOK is involved in regulation of cell adhesion.
2. Materials and methods
2.1. Generation of lok3=3 mice
A 5.5-kb HindIII^EcoRI fragment and a 2.5-kb HindIII^EcoRI
fragment, upstream and downstream regions of exon 1 of the lok
gene, respectively, were isolated from a genomic DNA library of
129/SVJ mice (Stratagene, CA, USA) and subcloned in conjunction
with neomycin-resistance gene into a plasmid-carrying thymidine ki-
nase gene [7]. Linearized construct was electroporated into W9.5 ES
cells [8]. Clones resistant to both G418 and gancyclovir were selected
and homologous recombination in these clones was checked by South-
ern blot analysis using a 1.2-kb EcoRI^BamHI fragment of the lok
gene as a probe (Fig. 1A) to obtain lok=3ES clones. lok3=3 mice
were generated from the ES clones by the standard method [8].
2.2. Re-aggregation assay of mitogen-stimulated lymphoblasts
Lymph node cells (2U106 cells/ml) were stimulated in vitro with
5 Wg/ml concanavalin a (Con A) for 2 days as described [9]. Con A
blasts were resuspended (2U106 cells/ml) in complete medium with
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15 mM K-methyl mannoside to prevent Con A-mediated cell adhe-
sion, in the absence or the presence of 50 Wg/ml of an anti-mouse
leukocyte-function-associated antigen (LFA-1) antibody, KBA. Each
cell suspension (200 Wl) was added to a well of 96-well £at bottom-
plate and shaken at 200 rpm in a CO2 incubator at 37‡C for 30 min.
For quanti¢cation of cell aggregation, samples were applied to Coult-
er Multisizer Counter (Coulter Scienti¢c Instruments, Hialeah, FL,
USA) as described [10]. The percentage of cells involved in aggrega-
tion = 100U[13(number of non-aggregated cells/number of input
cells)].
2.3. Antibodies and £ow cytometric analysis
Cells were incubated with antibodies speci¢c to LFA-1 (KBA),
intercellular adhesion molecule (ICAM)-1 (KAT-1), ICAM-2 (Phar-
Mingen, CA, USA), washed and then stained with FITC-goat F(abP)2
anti-rat IgG (Tago Immunologicals, CA, USA). Stained cells were
analyzed by FACSCalibur (Becton Dickinson, San Jose, CA, USA).
2.4. ICAM-1 binding assay and confocal microscopic analysis
Experiments were performed according to the method of Stewart et
al. [11]. Brie£y, Con A blasts were suspended (1U105 cells/50 Wl) in
staining bu¡er (PBS/5 mM Mg2/1 mM EGTA/0.2% BSA) and in-
cubated with 20 Wg/ml of soluble ICAM-1 chimeric with the Fc por-
tion of human IgG1 (D1D2-IgG) [12]. After a 30 min incubation
either at 37 or 4‡C, cells were reacted with 15 Wg/ml of FITC-goat
anti-human IgG Fc speci¢c antibody (Jackson Immuno Research
Laboratories, PA, USA) for 20 min on ice and applied to FACSCa-
libur. Stained cells were also examined with confocal laser scanning
microscopy (LSM510, Carl Zeiss, Germany) after ¢xation with 3%
formalin/PBS for 30 min at RT. Fixation of the cells before incuba-
tion with the FITC-labeled second antibody gave comparable results
even though the background of £uorescence became a little higher
(data not shown). In each sample from lok3=3 or lok= mice, 100
cells were analyzed for the presence of cap formation by using a 3D
projection image analyzer (Carl Zeiss). Cap formation was classi¢ed
in three types, 1/4 cap, 1/2 cap and patch. Cells showing £uorescence
on approximately 25 and 50% of the membrane periphery were con-
sidered as having 1/4 and 1/2 cap, respectively. Cells showing £uores-
cence in small, irregular clusters disseminated throughout the cell sur-
face without obvious polar distribution were considered as having
patch.
3. Results
3.1. Generation of lok3=3 mice
For generation of LOK-de¢cient mice, a targeting vector
shown in Fig. 1A was used to replace the exon 1 of the lok
gene with a neomycin-resistance gene. Southern blot analysis
of mouse tail DNA showed the correct targeting of the lok
locus and identi¢ed the genotype of progeny (Fig. 1B). The
absence of LOK expression in homozygous mice was con-
¢rmed by Western blot (Fig. 1C). An intercross of heterozy-
gotes produced wild-type (lok=), heterozygous (lok=3) and
homozygous (lok3=3) o¡spring at the expected Mendelian ra-
tio. lok3=3 mice did not exhibit any obvious gross histopatho-
logic abnormalities. Flow cytometric analysis showed a nor-
mal distribution of B cells, T cells and their precursors in the
bone marrow, thymus, spleen and lymph nodes of lok3=3
mice (data not shown), indicating that their lymphocytes de-
veloped normally.
3.2. Enhanced cell adhesion in mitogen-stimulated T cells from
lok3=3 mice
To examine possible functional alteration of lok3=3 lym-
phocytes, lymphocytes obtained from various lymphoid or-
gans were stimulated in vitro with mitogens such as LPS
and Con A, antibodies speci¢c to IgM, CD40, CD3 and
CD28 or IL-2. Proliferation of B and T cells from lok3=3
mice was comparable to that of cells from lok= mice as
judged by thymidine uptake and cell counts (data not shown).
Interestingly, however, we noticed that Con A-stimulated T
cell blasts from lok3=3 mice formed much larger and tighter
aggregates than those from wild-type littermates did (Fig.
2A). No remarkable di¡erence was observed in the aggrega-
tion of Con A blasts derived from lok= and lok=3 mice
(data not shown). To quantitate the extent of cell aggregation,
the re-aggregation assay was performed under shaking condi-
tions. Many of the lok3=3 cells formed aggregates again (Fig.
2B, top, right), whereas most of the lok= cells remained as
single cells and only some cells formed aggregates but smaller
than those formed by the lok3=3 cells (Fig. 2B, top, left).
Quantitative analysis with the multisizer counter revealed
that about 50% of lok3=3 cells were involved in cellular ag-
gregation, while only 15% of the lok= cells were involved
(Fig. 2C). These results indicated that cell adhesion of Con A
blasts was enhanced in the absence of LOK.
3.3. Enhanced clustering of active LFA-1 on lok3=3 Con A
blasts
When anti-LFA-1 antibody was added in culture during the
re-aggregation assay, the aggregation of lok3=3 Con A blasts
was almost completely blocked as in the case of lok= Con A
blasts (Fig. 2B lower panels and Fig. 2C). Therefore, the en-
hanced cellular aggregation observed in lok3=3 Con A blasts
was thought to be mediated mainly by the LFA-1/ICAMs
adhesion pathway. However, £ow cytometric analysis showed
no signi¢cant di¡erence between lok3=3 and lok= unstimu-
lated or Con A-stimulated cells in the expression levels of
LFA-1, ICAM-1 and ICAM-2 (Fig. 3A).
We next investigated the surface expression level of the
active form of LFA-1, which is competent to bind ICAM-1,
by using soluble ICAM-1/Fc chimeric protein (D1D2-IgG).
As reported previously [11], unstimulated lok= cells bound
Fig. 1. Generation of lok3=3 mice by gene targeting. A: Partial re-
striction maps are shown for the wild-type lok locus (top), the tar-
geting vector (middle) and the targeted lok locus (bottom). Neo,
neomycin resistance gene; Tk, Herpes simplex virus-thymidine ki-
nase. Restriction sites; B, BamHI; E, EcoRI. B: Southern blot anal-
ysis of o¡spring from intercrosses of lok=3 mice. Tail DNA was
digested with BamHI and hybridized with the 1.2 kb EcoRI^BamHI
fragment shown in A. Bands corresponding to the wild-type allele
(9.3 kb) and those to the mutant allele (4.2 kb) were indicated.
C: Western blot analysis of LOK protein. The expression of LOK
protein in splenocytes from lok=, lok=3 and lok3=3 mice was ex-
amined by Western blotting with anti-LOK antibody [5].
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little if any D1D2-IgG while lok= Con A blasts bound sub-
stantial amounts of D1D2-IgG when incubated at 37‡C (Fig.
3B). To our surprise, the amount of D1D2-IgG bound to
lok3=3 Con A blasts was comparable to that observed in
lok= Con A blasts as judged by £uorescence intensity
(Fig. 3B). The incubation at 4‡C instead of 37‡C abolished
this binding, indicating that the observed binding of D1D2-
IgG to Con A blasts was temperature-dependent and not non-
speci¢c.
Intriguingly, the analysis with confocal microscopy revealed
that the cell surface distribution of active LFA-1 molecules
reactive to D1D2-IgG di¡ered in lok3=3 and lok= Con A
blasts. LFA-1 molecules binding to D1D2-IgG were localized
in large clusters on lok3=3 Con A blasts while they were
rather dispersed on lok= Con A blasts (Fig. 4A, lower pan-
els). Analysis with a 3D projection image analyzer revealed
that approximately 60% of the lok3=3 cells formed caps of
LFA-1 while only 20% of the lok= cells formed such caps
(Fig. 4B). The di¡erence was especially prominent when
highly capped cells were compared. About 25% of the
lok3=3 cells formed ‘1/4 cap’ while only 2% of the lok= cells
did. These results indicate that the clustering of active LFA-1
was greatly enhanced in the absence of LOK.
4. Discussion
LFA-1 is a leukocyte-speci¢c adhesion receptor that be-
Fig. 3. lok= and lok3=3 Con A blasts express comparable levels
of LFA-1, ICAM-1/2 and active form of LFA-1 on the surface.
A: Unstimulated cells and Con A blasts from lok= and lok3=3
mice were stained with antibodies speci¢c to LFA-1, ICAM-1 or
ICAM-2. The histograms are shown as overlaid with those of nega-
tive controls (dotted lines). B: Unstimulated cells and Con A blasts
from lok= and lok3=3 mice were reacted with soluble ICAM-1/Fc
chimeric protein either at 37‡C (bold lines) or 4‡C (thin lines). One
representative experiment of six is shown as histograms overlaid
with those of negative controls (NC, dotted lines).
Fig. 2. Enhanced cell adhesion through LFA-1/ICAMs interaction
in Con A blasts from lok3=3 mice. A: Lymph node cells from
lok= and lok3=3 mice were cultured with Con A at 37‡C for
2 days. Photomicrographs were taken before (upper panels) and
after the culture (lower panels). B: Con A blasts from lok= and
lok3=3 mice were resuspended in the absence (upper panels) or the
presence of 50 Wg/ml of anti-LFA-1 antibody (lower panels) and
200 Wl of each cell suspension was shaken at 200 rpm at 37‡C for
30 min. Photomicrographs taken just after the 30 min-shaking were
shown. C: The extent of cell re-aggregation shown in (B) was quan-
ti¢ed with a multisizer counter. Data are shown derived from three
independent experiments, triplicate in each.
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longs to the L2 family of integrins and coordinates distinct
adhesive and signaling interaction in the immune system [13^
15]. LFA-1 expressed by leukocytes is generally not functional
and must be activated through intracellular signaling to bind
its ligand ICAMs. Though the precise mechanism by which
the adhesive function of LFA-1 is regulated remains to be
determined, it has been shown that the qualitative rather
than quantitative change of LFA-1 is crucial in the regulation
[13^15]. At least two mechanisms are thought to be involved
in the qualitative change. One is the conformational alteration
of LFA-1 that could a¡ect the intrinsic a⁄nity of LFA-1 [15].
The other is the cell surface distribution (clustered/dispersed)
of LFA-1 that could a¡ect the avidity for ligands [16,17].
In the present study, we demonstrated that homotypic cell
aggregation was greatly enhanced in mitogen-stimulated T
lymphoblasts derived from mice de¢cient for LOK. Their ag-
gregation was completely blocked by function-blocking anti-
LFA-1 antibody. Therefore, the enhancement of cell adhesion
in the absence of LOK appears to be attributed to the accel-
erated LFA-1/ICAMs interaction rather than the induction or
activation of other adhesion pathways. The expression levels
of LFA-1 and ICAMs on the cell surface was found not to be
Fig. 4. Enhanced clustering of active LFA-1 on lok3=3 Con A blasts. A: Unstimulated cells and Con A blasts from lok= and lok3=3 mice
were stained with soluble ICAM-1/Fc chimeric protein as in Fig. 3B and examined with confocal laser scanning microscopy. B: In each sample
from lok= or lok3=3 mice, 100 cells were analyzed for the presence of cap formation of LFA-1 by using 3D projection image analyzer. Cap
formation was classi¢ed in three types: 1/4 cap, 1/2 cap and patch. Percentages of cells forming cap of LFA-1 are shown.
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altered in the absence of LOK, indicating that loss of LOK
might a¡ect the qualitative change of these adhesion mole-
cules. Indeed, the analysis with soluble ICAM-1 revealed
that clustering of active LFA-1 on mitogen-stimulated T lym-
phoblasts was accelerated in the absence of LOK. The amount
of active LFA-1 detected by soluble ICAM-1 was comparable
in the presence and absence of LOK. These results strongly
suggest that LOK is involved in the qualitative regulation of
LFA-1 through control of the cell surface distribution of ac-
tive LFA-1.
It remains unclear at present how LOK contributes to the
regulation of LFA-1 distribution. Previous studies have indi-
cated that the actin cytoskeleton plays an important role in
the regulation of LFA-1 clustering [16^18]. LFA-1 is co-local-
ized with F-actin [18] and concentrated in the area of contact
between interacting cells [19]. Disruption of the F-actin cyto-
skeleton by cytochalasin D results in the disappearance of
LFA-1 clusters [18]. Therefore, one may assume that an intra-
cellular serine/threonine kinase LOK could be involved in the
regulation of LFA-1 clustering through actin reorganization.
In this sense, it is intriguing to note that PAK1, a member of
the PAK subfamily, has been shown to dissolve focal adhe-
sion and stress ¢bers when overexpressed in ¢broblasts
[20,21]. Moreover, it was recently reported that overexpres-
sion of a member of the GCK subfamily TNIK in adherent
cells resulted in the disruption of the F-actin structure and the
inhibition of cell spreading [22]. Taken together, it is plausible
that LOK could participate in modulation of the cytoskeleton
to control the cell surface distribution of LFA-1.
Even though we observed the enhanced cellular aggregation
of lok3=3 Con A blasts in vitro, no remarkable alteration was
detected in immune responses of lok3=3 mice as far as we
examined antibody production, formation of germinal center
and cytotoxic activity of activated killer cells (data not
shown). Physiological stimuli to induce immune responses in
vivo might be much weaker than the extraordinary stimula-
tion with Con A in vitro. Under such weaker stimulation, the
loss of LOK function could be compensated by SLK, another
member of the GCK subfamily, which is ubiquitously ex-
pressed and shows very high similarity to LOK in both kinase
and regulatory domains [23,24]. Establishment of LOK/SLK
double de¢cient mice would be needed to explore this possi-
bility.
Evidence provided in the present study gives an important
insight into the possible relationship between the GCK sub-
family kinases and the regulation of cell adhesion. In order to
clarify a pathway connecting LOK, the cytoskeleton and ad-
hesion molecules, we are currently identifying a substrate(s) of
LOK and a molecule(s) associated with LOK in lymphocytes.
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